Literature DB >> 11983456

Progressive reversion of clinical and molecular phenotype in a child with liver mitochondrial DNA depletion.

Pierre-Henri Ducluzeau1, Alain Lachaux, Raymonde Bouvier, Hervé Duborjal, Georges Stepien, Dominique Bozon, Bénédicte Mousson de Camaret.   

Abstract

Mitochondrial DNA depletion is a well established cause of severe liver failure in infancy. The autosomal inheritance of this quantitative mitochondrial DNA defect supports the involvement of a nuclear gene in the control of mitochondrial DNA level. We previously described a case of a 28-month-old child presenting with a progressive liver fibrosis due to a mitochondrial DNA depletion (85% at 12 months of age). As this syndrome was clinically liver-restricted, a liver transplant was initially discussed. We report the clinical, biochemical and molecular follow-up of this child, now 6 years old. The patient displayed a spontaneous gradual improvement of his liver function with continuous increment of clotting factor values since 32 months of age. A marked reduction of the previous extensive fibrosis was evidenced on a liver biopsy performed at 46 months of age associated with a dramatic decrease of the mitochondrial DNA depletion (35%). Consequently, an almost complete restoration of respiratory chain activities containing mitochondrial DNA-encoded subunits was observed. This is the first report of a revertant phenotype in liver mitochondrial DNA depletion syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983456     DOI: 10.1016/s0168-8278(02)00021-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

Authors:  Elisabeth De Greef; John Christodoulou; Ian E Alexander; Albert Shun; Edward V O'Loughlin; David R Thorburn; Vicki Jermyn; Michael O Stormon
Journal:  JIMD Rep       Date:  2011-11-04

2.  Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion.

Authors:  Bénédicte Mousson de Camaret; Jan-Willem Taanman; Sylvie Padet; Maïté Chassagne; Martine Mayençon; Pascale Clerc-Renaud; Ginette Mandon; Marie-Thérèse Zabot; Alain Lachaux; Dominique Bozon
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

3.  Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.

Authors:  Reine Note; Caroline Maisonneuve; Philippe Lettéron; Gilles Peytavin; Fatima Djouadi; Anissa Igoudjil; Marie-Christine Guimont; Michel Biour; Dominique Pessayre; Bernard Fromenty
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

4.  Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.

Authors:  Neil Ashley; Anthony O'Rourke; Conrad Smith; Susan Adams; Vasantha Gowda; Massimo Zeviani; Garry K Brown; Carl Fratter; Joanna Poulton
Journal:  Hum Mol Genet       Date:  2008-05-16       Impact factor: 6.150

5.  Mitochondrial DNA depletion and fatal infantile hepatic failure due to mutations in the mitochondrial polymerase γ (POLG) gene: a combined morphological/enzyme histochemical and immunocytochemical/biochemical and molecular genetic study.

Authors:  J Müller-Höcker; R Horvath; S Schäfer; H Hessel; W Müller-Felber; J Kühr; W C Copeland; P Seibel
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.